We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NVCT market cap is 119.31M. The company's latest EPS is USD -1.2127 and P/E is -5.42.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.1M | -5.77M | -6.16M | -6.87M | -4.4M |
| Net Income | -4.05M | -5.71M | -5.88M | -6.62M | -4.17M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -10k | -12.89M | -19.23M | -22.9M |
| Net Income | -10k | -12.89M | -19.09M | -22.26M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 16.21M | 24.94M | 22.26M | 19.19M | 19.71M |
| Total Liabilities | 3.93M | 4.61M | 5.58M | 6.98M | 5.69M |
| Total Equity | 12.27M | 20.33M | 16.69M | 12.2M | 14.02M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 0 | 6.66M | 20.41M | 19.19M |
| Total Liabilities | 10k | 2.42M | 6.19M | 6.98M |
| Total Equity | -10k | -11.01M | 14.22M | 12.2M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -4.78M | -8.86M | -12.1M | -15.95M | -4.36M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 252k | 13.47M | 14.17M | 15.09M | 4.7M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | -9.5M | -13.56M | -15.95M |
| Investing | N/A | N/A | N/A | N/A |
| Financing | N/A | 15.25M | 27.81M | 15.09M |
| Market Cap | 119.31M |
| Price to Earnings Ratio | -5.42 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.31 |
| Price to Book Ratio | 9.88 |
| Dividend Yield | - |
| Shares Outstanding | 18.36M |
| Average Volume (1 week) | 131.89k |
| Average Volume (1 Month) | 78.13k |
| 52 Week Change | -61.58% |
| 52 Week High | 16.99 |
| 52 Week Low | 5.85 |
| Spread (Intraday) | 3.07 (34.89%) |
| Company Name | Nuvectis Pharma Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.nuvectis.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
